Beacon Capital Management, LLC Bristol Myers Squibb CO Transaction History
Beacon Capital Management, LLC
- $625 Million
- Q4 2024
A detailed history of Beacon Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Beacon Capital Management, LLC holds 2,884 shares of BMY stock, worth $165,599. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,884
Previous 2,902
0.62%
Holding current value
$165,599
Previous $150,000
8.67%
% of portfolio
0.03%
Previous 0.03%
Shares
10 transactions
Others Institutions Holding BMY
# of Institutions
2,632Shares Held
1.47BCall Options Held
31.5MPut Options Held
34.9M-
Vanguard Group Inc Valley Forge, PA189MShares$10.8 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.11 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.33 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.47 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.46 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $122B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...